{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T18:06:05Z","timestamp":1790013965608,"version":"4.0.1"},"reference-count":120,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T00:00:00Z","timestamp":1788393600000},"content-version":"vor","delay-in-days":33,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharm Res"],"published-print":{"date-parts":[[2026,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Subcutaneous (SC) administration has emerged as a promising route for delivering large therapeutic proteins, offering advantages such as improved patient convenience and reduced healthcare costs. However, the mechanisms that regulate the uptake of these macromolecules are not yet fully understood. A recent surge in computational and experimental studies has systematically analyzed the transport of large proteins from the SC injection site to the lymphatic system, advancing our understanding of how tissue environments and injection parameters affect lymphatic uptake kinetics. This review summarizes the current literature on factors affecting the lymphatic uptake of subcutaneously administered large therapeutic proteins. First, we outline the transport mechanisms of therapeutic proteins from the local SC injection site to initial lymphatics. Then we analyze the impact of injection site, tissue properties, device selection, and molecular characteristics, on lymphatic uptake kinetics and pharmacokinetics (PK). Finally, we evaluate how recent modeling and experimental advancements have transformed our mechanistic understanding of SC delivery.<\/jats:p>","DOI":"10.1007\/s11095-026-04171-8","type":"journal-article","created":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T00:47:29Z","timestamp":1788396449000},"page":"2607-2621","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A Review on Lymphatic Uptake of Large Therapeutic Proteins after Subcutaneous Injection"],"prefix":"10.1007","volume":"43","author":[{"given":"Ehsan","family":"Rahimi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxu","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenji","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Galen Huaiqiu","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3301-3193","authenticated-orcid":false,"given":"Arezoo M.","family":"Ardekani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,3]]},"reference":[{"key":"4171_CR1","doi-asserted-by":"crossref","unstructured":"Dimitrov DS. Therapeutic proteins. Therapeutic Proteins: Methods and Protocols. 2012;1\u201326.","DOI":"10.1007\/978-1-61779-921-1_1"},{"key":"4171_CR2","doi-asserted-by":"publisher","first-page":"313","DOI":"10.2165\/00003088-199732040-00004","volume":"32","author":"RM Reilly","year":"1997","unstructured":"Reilly RM, Domingo R, Sandhu J. Oral delivery of antibodies: future pharmacokinetic trends. Clin Pharmacokinet. 1997;32:313\u201323.","journal-title":"Clin Pharmacokinet"},{"key":"4171_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2020.120008","volume":"594","author":"X Zhong","year":"2021","unstructured":"Zhong X, Guo T, Vlachos P, Veilleux J-C, Shi GH, Collins DS, et al. An experimentally validated dynamic model for spring-driven autoinjectors. Int J Pharm. 2021;594:120008.","journal-title":"Int J Pharm"},{"key":"4171_CR4","doi-asserted-by":"crossref","unstructured":"Sree V, Zhong X, Bilionis I, Ardekani A, Tepole AB. Optimizing autoinjector devices using physics-based simulations and Gaussian processes. J Mech Behav Biomed Mater. 2023;140:105695.","DOI":"10.1016\/j.jmbbm.2023.105695"},{"issue":"3","key":"4171_CR5","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1002\/cpt.3145","volume":"115","author":"Z Li","year":"2024","unstructured":"Li Z, Du X, Huang SM, Wang Y-MC. Pharmacokinetics-bridging between autoinjectors and prefilled syringes for subcutaneous injection: Case examples revealing a knowledge gap. Clin Pharmacol Therapeutics. 2024;115(3):404\u20137.","journal-title":"Clin Pharmacol Therapeutics"},{"key":"4171_CR6","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1208\/s12248-012-9367-0","volume":"14","author":"WF Richter","year":"2012","unstructured":"Richter WF, Bhansali SG, Morris ME. Mechanistic determinants of biotherapeutics absorption following SC administration. AAPS J. 2012;14:559\u201370.","journal-title":"AAPS J"},{"key":"4171_CR7","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.jconrel.2018.08.001","volume":"286","author":"M Viola","year":"2018","unstructured":"Viola M, Sequeira J, Sei\u00e7a R, Veiga F, Serra J, Santos AC, et al. Subcutaneous delivery of monoclonal antibodies: How do we get there? J Control Release. 2018;286:301\u201314.","journal-title":"J Control Release"},{"key":"4171_CR8","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.jconrel.2021.06.038","volume":"336","author":"P Zou","year":"2021","unstructured":"Zou P, Wang F, Wang J, Lu Y, Tran D, Seo SK. Impact of injection sites on clinical pharmacokinetics of subcutaneously administered peptides and proteins. J Control Release. 2021;336:310\u201321.","journal-title":"J Control Release"},{"issue":"9","key":"4171_CR9","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1002\/psp4.12224","volume":"6","author":"JT Ryman","year":"2017","unstructured":"Ryman JT, Meibohm B. Pharmacokinetics of monoclonal antibodies. CPT Pharmacomet Syst Pharmacol. 2017;6(9):576\u201388.","journal-title":"CPT Pharmacomet Syst Pharmacol"},{"key":"4171_CR10","doi-asserted-by":"crossref","unstructured":"Rahimi E, Li C, Zhong X, Shi G, Ardekani A. The role of initial lymphatics in the absorption of monoclonal antibodies after subcutaneous injection. Computers in Biology and Medicine. 2024; 183:109193.","DOI":"10.1016\/j.compbiomed.2024.109193"},{"key":"4171_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2023.123687","volume":"650","author":"X Zhong","year":"2024","unstructured":"Zhong X, Liu Y, Ardekani AM. A compartment model for subcutaneous injection of monoclonal antibodies. Int J Pharm. 2024;650:123687.","journal-title":"Int J Pharm"},{"key":"4171_CR12","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1146\/annurev-fluid-122316-045259","volume":"50","author":"JE Moore Jr","year":"2018","unstructured":"Moore JE Jr, Bertram CD. Lymphatic system flows. Annu Rev Fluid Mech. 2018;50:459\u201382.","journal-title":"Annu Rev Fluid Mech"},{"issue":"1\u20132","key":"4171_CR13","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0169-409X(01)00150-8","volume":"50","author":"MA Swartz","year":"2001","unstructured":"Swartz MA. The physiology of the lymphatic system. Adv Drug Deliv Rev. 2001;50(1\u20132):3\u201320.","journal-title":"Adv Drug Deliv Rev"},{"issue":"1","key":"4171_CR14","first-page":"1205121","volume":"2018","author":"AKJ Gradel","year":"2018","unstructured":"Gradel AKJ, Porsgaard T, Lykkesfeldt J, Seested T, Gram-Nielsen S, Kristensen NR, et al. Factors affecting the absorption of subcutaneously administered insulin: effect on variability. J Diabetes Res. 2018;2018(1):1205121.","journal-title":"J Diabetes Res"},{"issue":"11","key":"4171_CR15","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1124\/dmd.114.059238","volume":"42","author":"WF Richter","year":"2014","unstructured":"Richter WF, Jacobsen B. Subcutaneous absorption of biotherapeutics: knowns and unknowns. Drug Metab Dispos. 2014;42(11):1881\u20139.","journal-title":"Drug Metab Dispos"},{"key":"4171_CR16","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1146\/annurev.bioeng.9.060906.151850","volume":"9","author":"MA Swartz","year":"2007","unstructured":"Swartz MA, Fleury ME. Interstitial flow and its effects in soft tissues. Annu Rev Biomed Eng. 2007;9:229\u201356.","journal-title":"Annu Rev Biomed Eng"},{"key":"4171_CR17","doi-asserted-by":"crossref","unstructured":"Datta-Mannan A, Estwick S, Zhou C, Choi H, Douglass NE, Witcher DR, Lu J, Beidler C, Millican R. Influence of physiochemical properties on the subcutaneous absorption and bioavailability of monoclonal antibodies. In: MAbs, Taylor & Francis. 2020. vol 12, p. 1770028.","DOI":"10.1080\/19420862.2020.1770028"},{"key":"4171_CR18","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1245\/s10434-007-9709-9","volume":"15","author":"H Suami","year":"2008","unstructured":"Suami H, Pan W-R, Mann GB, Taylor GI. The lymphatic anatomy of the breast and its implications for sentinel lymph node biopsy: a human cadaver study. Ann Surg Oncol. 2008;15:863\u201371.","journal-title":"Ann Surg Oncol"},{"key":"4171_CR19","doi-asserted-by":"crossref","unstructured":"Kolarsick PA, Kolarsick MA, Goodwin C. Anatomy and physiology of the skin. J Dermatol Nurses\u2019 Assoc. 2011;3(4):203\u201313.","DOI":"10.1097\/JDN.0b013e3182274a98"},{"key":"4171_CR20","doi-asserted-by":"crossref","unstructured":"Redondo PdAG, Gubert F, Zaverucha-doValle C, Dutra TPP, Ayres-Silva JdP, Fernandes N, et al. Lymphatic vessels in human adipose tissue. Cell Tissue Res. 2020;379:511\u201320.","DOI":"10.1007\/s00441-019-03108-5"},{"key":"4171_CR21","doi-asserted-by":"crossref","unstructured":"Scallan J, Huxley VH, Korthuis RJ. Capillary fluid exchange: regulation, functions, and pathology. In Colloquium Lectures on Integrated Systems Physiology From Molecules to Function. 2010. vol. 2, p. 1\u201394. Morgan & Claypool Publishers.","DOI":"10.4199\/C00006ED1V01Y201002ISP003"},{"issue":"1","key":"4171_CR22","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1002\/j.2040-4603.2019.tb00063.x","volume":"9","author":"JW Breslin","year":"2018","unstructured":"Breslin JW, Yang Y, Scallan JP, Sweat RS, Adderley SP, Murfee WL. Lymphatic vessel network structure and physiology. Compr Physiol. 2018;9(1):207.","journal-title":"Compr Physiol"},{"key":"4171_CR23","doi-asserted-by":"crossref","unstructured":"Suami H, Scaglioni MF. Lymphedema management: Anatomy of the lymphatic system and the lymphosome concept with reference to lymphedema. In Seminars in plastic surgery. 2018. vol. 32, p. 5, Thieme Medical Publishers.","DOI":"10.1055\/s-0038-1635118"},{"issue":"3","key":"4171_CR24","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/nrc3677","volume":"14","author":"SA Stacker","year":"2014","unstructured":"Stacker SA, Williams SP, Karnezis T, Shayan R, Fox SB, Achen MG. Lymphangiogenesis and lymphatic vessel remodelling in cancer. Nat Rev Cancer. 2014;14(3):159\u201372.","journal-title":"Nat Rev Cancer"},{"key":"4171_CR25","doi-asserted-by":"publisher","first-page":"509","DOI":"10.3389\/fphys.2020.00509","volume":"11","author":"F Zhang","year":"2020","unstructured":"Zhang F, Zarkada G, Yi S, Eichmann A. Lymphatic endothelial cell junctions: molecular regulation in physiology and diseases. Front Physiol. 2020;11:509.","journal-title":"Front Physiol"},{"issue":"2","key":"4171_CR26","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/0026-2862(76)90013-3","volume":"12","author":"S Elhay","year":"1976","unstructured":"Elhay S, Casley-Smith J. Mathematical model of the initial lymphatics. Microvasc Res. 1976;12(2):121\u201340.","journal-title":"Microvasc Res"},{"issue":"2","key":"4171_CR27","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/1350-4533(95)91885-K","volume":"17","author":"N Reddy","year":"1995","unstructured":"Reddy N, Patel K. A mathematical model of flow through the terminal lymphatics. Med Eng Phys. 1995;17(2):134\u201340.","journal-title":"Med Eng Phys"},{"issue":"3","key":"4171_CR28","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1115\/1.1568128","volume":"125","author":"E Mendoza","year":"2003","unstructured":"Mendoza E, Schmid-Sch\u00f6nbein GW. A model for mechanics of primary lymphatic valves. J Biomech Eng. 2003;125(3):407\u201314.","journal-title":"J Biomech Eng"},{"key":"4171_CR29","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1007\/s11538-015-0078-4","volume":"77","author":"C Heppell","year":"2015","unstructured":"Heppell C, Roose T, Richardson G. A model for interstitial drainage through a sliding lymphatic valve. Bull Math Biol. 2015;77:1101\u201331.","journal-title":"Bull Math Biol"},{"key":"4171_CR30","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1679\/aohc.53.Suppl_107","volume":"53","author":"GW Schmid-Sch\u00f6nbein","year":"1990","unstructured":"Schmid-Sch\u00f6nbein GW. Mechanisms causing initial lymphatics to expand and compress to promote lymph flow. Arch Histol Cytol. 1990;53:107\u201314.","journal-title":"Arch Histol Cytol"},{"issue":"1","key":"4171_CR31","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41392-023-01723-x","volume":"9","author":"Z Hu","year":"2024","unstructured":"Hu Z, Zhao X, Wu Z, Qu B, Yuan M, Xing Y, et al. Lymphatic vessel: origin, heterogeneity, biological functions, and therapeutic targets. Signal Transduct Target Ther. 2024;9(1):9.","journal-title":"Signal Transduct Target Ther"},{"issue":"5","key":"4171_CR32","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1080\/01926230600867727","volume":"34","author":"CL Willard-Mack","year":"2006","unstructured":"Willard-Mack CL. Normal structure, function, and histology of lymph nodes. Toxicol Pathol. 2006;34(5):409\u201324.","journal-title":"Toxicol Pathol"},{"issue":"3","key":"4171_CR33","doi-asserted-by":"publisher","first-page":"258","DOI":"10.3400\/avd.ra.12.00046","volume":"5","author":"F Ikomi","year":"2012","unstructured":"Ikomi F, Kawai Y, Ohhashi T. Recent advance in lymph dynamic analysis in lymphatics and lymph nodes. Ann Vasc Dis. 2012;5(3):258\u201368.","journal-title":"Ann Vasc Dis"},{"issue":"4","key":"4171_CR34","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1089\/lrb.2015.0028","volume":"13","author":"M Jafarnejad","year":"2015","unstructured":"Jafarnejad M, Woodruff MC, Zawieja DC, Carroll MC, Moore J Jr. Modeling lymph flow and fluid exchange with blood vessels in lymph nodes. Lymphat Res Biol. 2015;13(4):234\u201347.","journal-title":"Lymphat Res Biol"},{"issue":"1","key":"4171_CR35","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s10928-011-9232-2","volume":"39","author":"DK Shah","year":"2012","unstructured":"Shah DK, Betts AM. Towards a platform PBPK model to characterize the plasma and tissue disposition of monoclonal antibodies in preclinical species and human. J Pharmacokinet Pharmacodyn. 2012;39(1):67\u201386.","journal-title":"J Pharmacokinet Pharmacodyn"},{"key":"4171_CR36","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/s41577-022-00821-1","volume":"23","author":"M Pyzik","year":"2023","unstructured":"Pyzik M, Kozicky LK, Gandhi AK, Blumberg RS. The therapeutic age of the neonatal Fc receptor. Nat Rev Immunol. 2023;23:415\u201332.","journal-title":"Nat Rev Immunol"},{"issue":"3","key":"4171_CR37","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1002\/eji.1830260327","volume":"26","author":"V Ghetie","year":"1996","unstructured":"Ghetie V, Hubbard JG, Kim J-K, Tsen M-F, Lee Y, Ward ES. Abnormally short serum half-lives of IgG in $$\\beta $$2-microglobulin-deficient mice. Eur J Immunol. 1996;26(3):690\u20136.","journal-title":"Eur J Immunol"},{"issue":"4","key":"4171_CR38","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1046\/j.1365-2567.1996.d01-775.x","volume":"89","author":"E Israel","year":"1996","unstructured":"Israel E, Wilsker D, Hayes K, Schoenfeld D, Simister N. Increased clearance of IgG in mice that lack $$\\beta $$2-microglobulin: possible protective role of FcRn. Immunology. 1996;89(4):573\u20138.","journal-title":"Immunology"},{"issue":"6","key":"4171_CR39","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1369\/0022155417705095","volume":"65","author":"S Latvala","year":"2017","unstructured":"Latvala S, Jacobsen B, Otteneder MB, Herrmann A, Kronenberg S. Distribution of FcRn across species and tissues. J Histochem Cytochem. 2017;65(6):321\u201333.","journal-title":"J Histochem Cytochem"},{"issue":"5","key":"4171_CR40","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1080\/19420862.2018.1458808","volume":"10","author":"WF Richter","year":"2018","unstructured":"Richter WF, Christianson GJ, Frances N, Grimm HP, Proetzel G, Roopenian DC. Hematopoietic cells as site of first-pass catabolism after subcutaneous dosing and contributors to systemic clearance of a monoclonal antibody in mice. MAbs. 2018;10(5):803\u201313.","journal-title":"MAbs"},{"issue":"5","key":"4171_CR41","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1038\/clpt.2008.170","volume":"84","author":"W Wang","year":"2008","unstructured":"Wang W, Wang E, Balthasar J. Monoclonal antibody pharmacokinetics and pharmacodynamics. Clin Pharmacol Therapeutics. 2008;84(5):548\u201358.","journal-title":"Clin Pharmacol Therapeutics"},{"key":"4171_CR42","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1007\/s11095-011-0578-3","volume":"29","author":"L Kagan","year":"2012","unstructured":"Kagan L, Turner MR, Balu-Iyer SV, Mager DE. Subcutaneous absorption of monoclonal antibodies: role of dose, site of injection, and injection volume on rituximab pharmacokinetics in rats. Pharm Res. 2012;29:490\u20139.","journal-title":"Pharm Res"},{"issue":"4","key":"4171_CR43","first-page":"570","volume":"44","author":"RF Uren","year":"2003","unstructured":"Uren RF, Howman-Giles R, Thompson JF. Patterns of lymphatic drainage from the skin in patients with melanoma. J Nucl Med. 2003;44(4):570\u201382.","journal-title":"J Nucl Med"},{"issue":"6","key":"4171_CR44","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1111\/1346-8138.12506","volume":"41","author":"M Fujiwara","year":"2014","unstructured":"Fujiwara M, Sawada M, Kasuya A, Matsushita Y, Yamada M, Fukamizu H, et al. Measurement of cutaneous lymphatic flow rates in patients with skin cancer: area extraction method. J Dermatol. 2014;41(6):498\u2013504.","journal-title":"J Dermatol"},{"issue":"2","key":"4171_CR45","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1042\/cs1010131","volume":"101","author":"A Stanton","year":"2001","unstructured":"Stanton A, Svensson W, Mellor R, Peters A, Levick J, Mortimer P. Differences in lymph drainage between swollen and non-swollen regions in arms with breast-cancer-related lymphoedema. Clin Sci. 2001;101(2):131\u201340.","journal-title":"Clin Sci"},{"issue":"5","key":"4171_CR46","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1042\/CS20050277","volume":"110","author":"AW Stanton","year":"2006","unstructured":"Stanton AW, Modi S, Mellor RH, Peters AM, Svensson WE, Levick JR, et al. A quantitative lymphoscintigraphic evaluation of lymphatic function in the swollen hands of women with lymphoedema following breast cancer treatment. Clin Sci. 2006;110(5):553\u201361.","journal-title":"Clin Sci"},{"issue":"6","key":"4171_CR47","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1185\/03007995.2010.481203","volume":"26","author":"MA Gibney","year":"2010","unstructured":"Gibney MA, Arce CH, Byron KJ, Hirsch LJ. Skin and subcutaneous adipose layer thickness in adults with diabetes at sites used for insulin injections: implications for needle length recommendations. Curr Med Res Opin. 2010;26(6):1519\u201330.","journal-title":"Curr Med Res Opin"},{"issue":"12","key":"4171_CR48","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1089\/dia.2014.0111","volume":"16","author":"L Hirsch","year":"2014","unstructured":"Hirsch L, Byron K, Gibney M. Intramuscular risk at insulin injection sites\u2014measurement of the distance from skin to muscle and rationale for shorter-length needles for subcutaneous insulin therapy. Diabetes Technol Therapeutics. 2014;16(12):867\u201373.","journal-title":"Diabetes Technol Therapeutics"},{"key":"4171_CR49","doi-asserted-by":"crossref","unstructured":"Dou Z, Eshraghi J, Guo T, Veilleux J-C, Duffy KH, Shi GH, et al. Performance characterization of spring actuated autoinjector devices for Emgality and Aimovig. Curr Med Res Opin. 2020;36(8):1343\u201354.","DOI":"10.1080\/03007995.2020.1783219"},{"issue":"3","key":"4171_CR50","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/j.ejrad.2006.01.008","volume":"58","author":"V Chan","year":"2006","unstructured":"Chan V, Colville J, Persaud T, Buckley O, Hamilton S, Torreggiani W. Intramuscular injections into the buttocks: are they truly intramuscular? Eur J Radiol. 2006;58(3):480\u20134.","journal-title":"Eur J Radiol"},{"issue":"4","key":"4171_CR51","first-page":"519","volume":"80","author":"T Hida","year":"2018","unstructured":"Hida T, Ando K, Kobayashi K, Ito K, Tsushima M, Kobayakawa T, et al. Ultrasound measurement of thigh muscle thickness for assessment of sarcopenia. Nagoya J Med Sci. 2018;80(4):519.","journal-title":"Nagoya J Med Sci"},{"issue":"2","key":"4171_CR52","doi-asserted-by":"publisher","first-page":"56","DOI":"10.4103\/tjps.TJPS_2_17","volume":"26","author":"P Oltulu","year":"2018","unstructured":"Oltulu P, Ince B, Kokbudak N, Findik S, Kilinc F. Measurement of epidermis, dermis, and total skin thicknesses from six different body regions with a new ethical histometric technique. Turkish J Plastic Surg. 2018;26(2):56\u201361.","journal-title":"Turkish J Plastic Surg"},{"issue":"1","key":"4171_CR53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-017-10110-w","volume":"7","author":"H Kim","year":"2017","unstructured":"Kim H, Park H, Lee SJ. Effective method for drug injection into subcutaneous tissue. Sci Rep. 2017;7(1):1\u201311.","journal-title":"Sci Rep"},{"key":"4171_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.mvr.2021.104228","volume":"139","author":"E Rahimi","year":"2022","unstructured":"Rahimi E, Aramideh S, Han D, Gomez H, Ardekani AM. Transport and lymphatic uptake of monoclonal antibodies after subcutaneous injection. Microvasc Res. 2022;139:104228.","journal-title":"Microvasc Res"},{"key":"4171_CR55","doi-asserted-by":"crossref","unstructured":"Comley K, Fleck NA. A micromechanical model for the Young\u2019s modulus of adipose tissue. Int J Solids Struct. 2010;47(21):2982\u201390.","DOI":"10.1016\/j.ijsolstr.2010.07.001"},{"issue":"8","key":"4171_CR56","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0104054","volume":"9","author":"M Thomsen","year":"2014","unstructured":"Thomsen M, Hernandez-Garcia A, Mathiesen J, Poulsen M, S\u00f8rensen DN, Tarnow L, et al. Model study of the pressure build-up during subcutaneous injection. PLoS ONE. 2014;9(8):e104054.","journal-title":"PLoS ONE"},{"key":"4171_CR57","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.ejps.2015.08.012","volume":"79","author":"M Thomsen","year":"2015","unstructured":"Thomsen M, Rasmussen CH, Refsgaard HH, Pedersen K-M, Kirk RK, Poulsen M, et al. Spatial distribution of soluble insulin in pig subcutaneous tissue: effect of needle length, injection speed and injected volume. Eur J Pharm Sci. 2015;79:96\u2013101.","journal-title":"Eur J Pharm Sci"},{"key":"4171_CR58","doi-asserted-by":"crossref","unstructured":"Rahimi E, Gomez H, Ardekani AM. Transport and distribution of biotherapeutics in different tissue layers after subcutaneous injection. International Journal of Pharmaceutics. 2022;626:122125.","DOI":"10.1016\/j.ijpharm.2022.122125"},{"issue":"1 Suppl","key":"4171_CR59","first-page":"130s","volume":"21","author":"N Varkhede","year":"2018","unstructured":"Varkhede N, Forrest ML. Understanding the monoclonal antibody disposition after subcutaneous administration using a minimal physiologically based pharmacokinetic model. J Pharm Pharmaceut Sci. 2018;21(1 Suppl):130s.","journal-title":"J Pharm Pharmaceut Sci"},{"issue":"5","key":"4171_CR60","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1080\/17425247.2025.2477656","volume":"22","author":"R Derakhshandeh","year":"2025","unstructured":"Derakhshandeh R, Eshraghi J, Tavakolian M, Duffy KH, Veilleux J-C, Shi GH, et al. Performance characterization of spring-actuated prefilled pen devices for lebrikizumab and dupilumab. Expert Opin Drug Deliv. 2025;22(5):747\u201356.","journal-title":"Expert Opin Drug Deliv"},{"key":"4171_CR61","doi-asserted-by":"crossref","unstructured":"Derakhshandeh R, Meyers BA, Zhang J, Veilleux J-C, Shi GH, Vlachos PP. Subcutaneous depot formation and diffusion in autoinjector delivery: insights from high-speed synchrotron imaging. International Journal of Pharmaceutics. 2025;681:125804.","DOI":"10.1016\/j.ijpharm.2025.125804"},{"issue":"3","key":"4171_CR62","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1002\/cpdd.219","volume":"5","author":"H Struemper","year":"2016","unstructured":"Struemper H, Murtaugh T, Gilbert J, Barton ME, Fire J, Groark J, et al. Relative bioavailability of a single dose of belimumab administered subcutaneously by prefilled syringe or autoinjector in healthy subjects. Clin Pharmacol Drug Dev. 2016;5(3):208\u201315.","journal-title":"Clin Pharmacol Drug Dev"},{"issue":"8","key":"4171_CR63","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1002\/cpdd.455","volume":"7","author":"SS Anumolu","year":"2018","unstructured":"Anumolu SS, Lindgren S, Vemula J, Floch D, Reynolds C, Wallny H-J, et al. Bioequivalence of canakinumab injected subcutaneously via an autoinjector device or a prefilled safety syringe device in healthy subjects. Clin Pharmacol Drug Dev. 2018;7(8):829\u201336.","journal-title":"Clin Pharmacol Drug Dev"},{"issue":"1","key":"4171_CR64","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.clinthera.2020.11.014","volume":"43","author":"Y Zheng","year":"2021","unstructured":"Zheng Y, Abuqayyas L, Megally A, Fuhr R, Sa\u0142apa K, Downie J, et al. Tezepelumab pharmacokinetics, safety, and tolerability after administration via vial-and-syringe, accessorized prefilled syringe, or autoinjector: a randomized trial in healthy volunteers. Clin Ther. 2021;43(1):142\u201355.","journal-title":"Clin Ther"},{"issue":"7","key":"4171_CR65","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1016\/j.xphs.2016.04.009","volume":"105","author":"DV Doughty","year":"2016","unstructured":"Doughty DV, Clawson CZ, Lambert W, Subramony JA. Understanding subcutaneous tissue pressure for engineering injection devices for large-volume protein delivery. J Pharm Sci. 2016;105(7):2105\u201313.","journal-title":"J Pharm Sci"},{"issue":"6","key":"4171_CR66","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1080\/17425247.2023.2219891","volume":"20","author":"A Schneider","year":"2023","unstructured":"Schneider A, Jost R, Jordi C, Lange J. Autoinjectors for large-volume subcutaneous drug delivery: a review of current research and future directions. Expert Opin Drug Deliv. 2023;20(6):815\u201330.","journal-title":"Expert Opin Drug Deliv"},{"issue":"4","key":"4171_CR67","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1208\/s12248-011-9303-8","volume":"13","author":"MN Martinez","year":"2011","unstructured":"Martinez MN. Factors influencing the use and interpretation of animal models in the development of parenteral drug delivery systems. AAPS J. 2011;13(4):632\u201349.","journal-title":"AAPS J"},{"key":"4171_CR68","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.addr.2020.05.009","volume":"167","author":"M S\u00e1nchez-F\u00e9lix","year":"2020","unstructured":"S\u00e1nchez-F\u00e9lix M, Burke M, Chen HH, Patterson C, Mittal S. Predicting bioavailability of monoclonal antibodies after subcutaneous administration: open innovation challenge. Adv Drug Deliv Rev. 2020;167:66\u201377.","journal-title":"Adv Drug Deliv Rev"},{"key":"4171_CR69","doi-asserted-by":"crossref","unstructured":"Purcell M, Babee S, Galluppi M, Cline J, Hu G, Petrescu I, et al. Characterization of large volume subcutaneous injections using computed tomography imaging and simultaneous pressure measurements. Front Drug Delivery. 2023;3:1223177.","DOI":"10.3389\/fddev.2023.1223177"},{"issue":"6","key":"4171_CR70","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1007\/s11095-021-03062-4","volume":"38","author":"P Hou","year":"2021","unstructured":"Hou P, Zheng F, Corpstein CD, Xing L, Li T. Multiphysics modeling and simulation of subcutaneous injection and absorption of biotherapeutics: sensitivity analysis. Pharm Res. 2021;38(6):1011\u201330.","journal-title":"Pharm Res"},{"issue":"1","key":"4171_CR71","doi-asserted-by":"publisher","first-page":"127","DOI":"10.2140\/jomms.2011.6.127","volume":"6","author":"K Comley","year":"2011","unstructured":"Comley K, Fleck N. Deep penetration and liquid injection into adipose tissue. J Mech Mater Struct. 2011;6(1):127\u201340.","journal-title":"J Mech Mater Struct"},{"issue":"4","key":"4171_CR72","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1055\/s-0034-1368173","volume":"74","author":"C Jackisch","year":"2014","unstructured":"Jackisch C, M\u00fcller V, Maintz C, Hell S, Ataseven B. Subcutaneous administration of monoclonal antibodies in oncology. Geburtshilfe Frauenheilkd. 2014;74(4):343.","journal-title":"Geburtshilfe Frauenheilkd"},{"key":"4171_CR73","unstructured":"Haller MF. Converting intravenous dosing to subcutaneous dosing with recombinant human hyaluronidase. Advanstar Communications Inc; 2007."},{"key":"4171_CR74","doi-asserted-by":"publisher","first-page":"2000","DOI":"10.1007\/s11095-017-2229-9","volume":"34","author":"D Collins","year":"2017","unstructured":"Collins D, Kourtis L, Thyagarajapuram N, Sirkar R, Kapur S, Harrison M, et al. Optimizing the bioavailability of subcutaneously administered biotherapeutics through mechanochemical drivers. Pharm Res. 2017;34:2000\u201311.","journal-title":"Pharm Res"},{"key":"4171_CR75","unstructured":"US Food and Drug Administration. Draft guidance for industry: Bridging for drug-device and biologic-device combination products. 2019."},{"key":"4171_CR76","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1208\/s12248-020-0433-8","volume":"22","author":"P Hu","year":"2020","unstructured":"Hu P, Wang J, Florian J, Shatzer K, Stevens AM, Gertz J, et al. Systematic review of device parameters and design of studies bridging biologic-device combination products using prefilled syringes and autoinjectors. AAPS J. 2020;22:1\u20139.","journal-title":"AAPS J"},{"key":"4171_CR77","doi-asserted-by":"publisher","DOI":"10.1016\/j.cma.2020.113550","volume":"373","author":"M de Lucio","year":"2021","unstructured":"de Lucio M, Bures M, Ardekani AM, Vlachos PP, Gomez H. Isogeometric analysis of subcutaneous injection of monoclonal antibodies. Comput Methods Appl Mech Eng. 2021;373:113550.","journal-title":"Comput Methods Appl Mech Eng"},{"issue":"1","key":"4171_CR78","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s40259-025-00755-9","volume":"40","author":"B Bittner","year":"2026","unstructured":"Bittner B, Munoz J, Frank S, Dolton M, Ravanello R, Dembowski M, et al. Clinical qualification of subcutaneous injection devices for monoclonal antibodies. BioDrugs. 2026;40(1):5\u201321.","journal-title":"BioDrugs"},{"issue":"12","key":"4171_CR79","doi-asserted-by":"publisher","first-page":"3447","DOI":"10.1016\/j.xphs.2024.08.019","volume":"113","author":"J Gresham","year":"2024","unstructured":"Gresham J, Bruin G, Picci M, Bechtold-Peters K, Dimke T, Davies E, et al. Visualisation and quantification of subcutaneous injections of different volumes, viscosities and injection rates: an ex-vivo micro-CT study. J Pharm Sci. 2024;113(12):3447\u201356.","journal-title":"J Pharm Sci"},{"issue":"2","key":"4171_CR80","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/0095-8522(51)90036-0","volume":"6","author":"M Mooney","year":"1951","unstructured":"Mooney M. The viscosity of a concentrated suspension of spherical particles. J Colloid Sci. 1951;6(2):162\u201370.","journal-title":"J Colloid Sci"},{"issue":"4","key":"4171_CR81","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/0006-291X(77)90950-0","volume":"76","author":"PD Ross","year":"1977","unstructured":"Ross PD, Minton AP. Hard quasispherical model for the viscosity of hemoglobin solutions. Biochem Biophys Res Commun. 1977;76(4):971\u20136.","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"4171_CR82","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.ejpb.2010.08.002","volume":"76","author":"V Burckbuchler","year":"2010","unstructured":"Burckbuchler V, Mekhloufi G, Giteau AP, Grossiord J, Huille S, Agnely F. Rheological and syringeability properties of highly concentrated human polyclonal immunoglobulin solutions. Eur J Pharm Biopharm. 2010;76(3):351\u20136.","journal-title":"Eur J Pharm Biopharm"},{"key":"4171_CR83","doi-asserted-by":"publisher","first-page":"3102","DOI":"10.1007\/s11095-015-1690-6","volume":"32","author":"E Binabaji","year":"2015","unstructured":"Binabaji E, Ma J, Zydney AL. Intermolecular interactions and the viscosity of highly concentrated monoclonal antibody solutions. Pharm Res. 2015;32:3102\u20139.","journal-title":"Pharm Res"},{"issue":"6","key":"4171_CR84","doi-asserted-by":"publisher","first-page":"727","DOI":"10.4155\/tde.11.31","volume":"2","author":"H Mach","year":"2011","unstructured":"Mach H, Gregory SM, Mackiewicz A, Mittal S, Lalloo A, Kirchmeier M, et al. Electrostatic interactions of monoclonal antibodies with subcutaneous tissue. Ther Deliv. 2011;2(6):727\u201336.","journal-title":"Ther Deliv"},{"issue":"3","key":"4171_CR85","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1208\/s12248-023-00798-2","volume":"25","author":"P Zou","year":"2023","unstructured":"Zou P. Predicting human bioavailability of subcutaneously administered fusion proteins and monoclonal antibodies using human intravenous clearance or antibody isoelectric point. AAPS J. 2023;25(3):31.","journal-title":"AAPS J"},{"issue":"7","key":"4171_CR86","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1016\/j.bbapap.2009.02.010","volume":"1794","author":"SN Olsen","year":"2009","unstructured":"Olsen SN, Andersen KB, Randolph TW, Carpenter JF, Westh P. Role of electrostatic repulsion on colloidal stability of bacillus halmapalus alpha-amylase. Biochem Biophys Acta (BBA)-Proteins Proteom. 2009;1794(7):1058\u201365.","journal-title":"Biochem Biophys Acta (BBA)-Proteins Proteom"},{"issue":"4","key":"4171_CR87","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1021\/mp200566k","volume":"9","author":"S Yadav","year":"2012","unstructured":"Yadav S, Laue TM, Kalonia DS, Singh SN, Shire SJ. The influence of charge distribution on self-association and viscosity behavior of monoclonal antibody solutions. Mol Pharm. 2012;9(4):791\u2013802.","journal-title":"Mol Pharm"},{"issue":"1","key":"4171_CR88","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.bpj.2012.04.047","volume":"103","author":"BD Connolly","year":"2012","unstructured":"Connolly BD, Petry C, Yadav S, Demeule B, Ciaccio N, Moore JM, et al. Weak interactions govern the viscosity of concentrated antibody solutions: high-throughput analysis using the diffusion interaction parameter. Biophys J. 2012;103(1):69\u201378.","journal-title":"Biophys J"},{"key":"4171_CR89","doi-asserted-by":"crossref","unstructured":"Li C, Zhong X, Ardekani AM. Numerical studies of the lymphatic uptake rate. Computers in Biology and Medicine. 2023;165:107380.","DOI":"10.1016\/j.compbiomed.2023.107380"},{"issue":"9","key":"4171_CR90","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1021\/ja02242a004","volume":"40","author":"I Langmuir","year":"1918","unstructured":"Langmuir I. The adsorption of gases on plane surfaces of glass, mica and platinum. J Am Chem Soc. 1918;40(9):1361\u2013403.","journal-title":"J Am Chem Soc"},{"issue":"1\u20132","key":"4171_CR91","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.cis.2010.12.007","volume":"162","author":"M Rabe","year":"2011","unstructured":"Rabe M, Verdes D, Seeger S. Understanding protein adsorption phenomena at solid surfaces. Adv Coll Interface Sci. 2011;162(1\u20132):87\u2013106.","journal-title":"Adv Coll Interface Sci"},{"issue":"4","key":"4171_CR92","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1007\/s11095-024-03683-5","volume":"41","author":"X Dang","year":"2024","unstructured":"Dang X, Shih H, Sharma R, Angwin-Kaerner DT, Lin K, Kapur S, et al. Clinical investigation of large volume subcutaneous delivery up to 25 ml for lean and non-lean subjects. Pharm Res. 2024;41(4):751\u201363.","journal-title":"Pharm Res"},{"issue":"8","key":"4171_CR93","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1016\/j.xphs.2016.05.029","volume":"105","author":"R Mathaes","year":"2016","unstructured":"Mathaes R, Koulov A, Joerg S, Mahler H-C. Subcutaneous injection volume of biopharmaceuticals\u2014pushing the boundaries. J Pharm Sci. 2016;105(8):2255\u20139.","journal-title":"J Pharm Sci"},{"key":"4171_CR94","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.jconrel.2019.10.040","volume":"315","author":"IK Styles","year":"2019","unstructured":"Styles IK, Feeney OM, Nguyen T-H, Brundel DH, Kang DW, Clift R, et al. Removal of interstitial hyaluronan with recombinant human hyaluronidase improves the systemic and lymphatic uptake of cetuximab in rats. J Control Release. 2019;315:85\u201396.","journal-title":"J Control Release"},{"issue":"5","key":"4171_CR95","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1002\/cpt.2385","volume":"110","author":"MJ Dolton","year":"2021","unstructured":"Dolton MJ, Chesterman A, Moein A, Sink KM, Waitz A, Blondeau K, et al. Safety, tolerability, and pharmacokinetics of high-volume subcutaneous crenezumab, with and without recombinant human hyaluronidase in healthy volunteers. Clin Pharmacol Therapeutics. 2021;110(5):1337\u201348.","journal-title":"Clin Pharmacol Therapeutics"},{"key":"4171_CR96","doi-asserted-by":"crossref","unstructured":"Mirrashed F, Sharp J, Krause V, Morgan J, Tomanek B. Pilot study of dermal and subcutaneous fat structures by MRI in individuals who differ in gender, BMI, and cellulite grading. Skin Res Technol. 2004;10(3):161\u20138.","DOI":"10.1111\/j.1600-0846.2004.00072.x"},{"key":"4171_CR97","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1007\/s00276-010-0772-8","volume":"33","author":"L Lancerotto","year":"2011","unstructured":"Lancerotto L, Stecco C, Macchi V, Porzionato A, Stecco A, De Caro R. Layers of the abdominal wall: anatomical investigation of subcutaneous tissue and superficial fascia. Surg Radiol Anat. 2011;33:835\u201342.","journal-title":"Surg Radiol Anat"},{"issue":"23","key":"4171_CR98","doi-asserted-by":"publisher","first-page":"9185","DOI":"10.1073\/pnas.1206398109","volume":"109","author":"L Causey","year":"2012","unstructured":"Causey L, Cowin SC, Weinbaum S. Quantitative model for predicting lymph formation and muscle compressibility in skeletal muscle during contraction and stretch. Proc Natl Acad Sci. 2012;109(23):9185\u201390.","journal-title":"Proc Natl Acad Sci"},{"issue":"2","key":"4171_CR99","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1089\/lrb.2004.2.69","volume":"2","author":"D Negrini","year":"2004","unstructured":"Negrini D, Moriondo A, Mukenge S. Transmural pressure during cardiogenic oscillations in rodent diaphragmatic lymphatic vessels. Lymphat Res Biol. 2004;2(2):69\u201381.","journal-title":"Lymphat Res Biol"},{"key":"4171_CR100","doi-asserted-by":"crossref","unstructured":"Haynes FW. Factors which influence the flow and protein content of subcutaneous lymph in the dog: II. the effect of certain substances which alter the capillary circulation. Am J Physiol Legacy Content. 1932;101(4):612\u201320.","DOI":"10.1152\/ajplegacy.1932.101.4.612"},{"issue":"2","key":"4171_CR101","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1111\/j.1748-1716.1977.tb10364.x","volume":"99","author":"A Engeset","year":"1977","unstructured":"Engeset A, Olszewski W, Jaeger P, Sokolowski J, Theodorsen L. Twenty-four hour variation in flow and composition of leg lymph in normal men. Acta Physiol Scand. 1977;99(2):140\u20138.","journal-title":"Acta Physiol Scand"},{"issue":"1","key":"4171_CR102","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1113\/jphysiol.1987.sp016564","volume":"387","author":"J McGeown","year":"1987","unstructured":"McGeown J, McHale N, Thornbury K. The role of external compression and movement in lymph propulsion in the sheep hind limb. J Physiol. 1987;387(1):83\u201393.","journal-title":"J Physiol"},{"key":"4171_CR103","doi-asserted-by":"publisher","first-page":"461","DOI":"10.2165\/00007256-200535060-00001","volume":"35","author":"K Lane","year":"2005","unstructured":"Lane K, Worsley D, McKenzie D. Exercise and the lymphatic system: implications for breast-cancer survivors. Sports Med. 2005;35:461\u201371.","journal-title":"Sports Med"},{"issue":"5","key":"4171_CR104","doi-asserted-by":"publisher","first-page":"864","DOI":"10.4103\/2230-8210.117249","volume":"17","author":"SM Jain","year":"2013","unstructured":"Jain SM, Pandey K, Lahoti A, Rao PK. Evaluation of skin and subcutaneous tissue thickness at insulin injection sites in Indian, insulin na\u00efve, type-2 diabetic adult population. Indian J Endocrinol Metabolism. 2013;17(5):864\u201370.","journal-title":"Indian J Endocrinol Metabolism"},{"issue":"3","key":"4171_CR105","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/BF02306624","volume":"4","author":"RF Uren","year":"1997","unstructured":"Uren RF, Howman-Giles R, Thompson JF. Variation in cutaneous lymphatic flow rates. Ann Surg Oncol. 1997;4(3):279\u201380.","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"4171_CR106","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1097\/00008390-199806000-00012","volume":"8","author":"R Uren","year":"1998","unstructured":"Uren R, Howman-Giles R, Thompson J, Roberts J, Bernard E. Variability of cutaneous lymphatic flow rates in melanoma patients. Melanoma Res. 1998;8(3):279\u201382.","journal-title":"Melanoma Res"},{"issue":"3","key":"4171_CR107","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1089\/lrb.2012.0009","volume":"10","author":"V Akhras","year":"2012","unstructured":"Akhras V, Stanton AW, Levick JR, Mortimer PS. A quantitative examination of lymph drainage from perilesion skin in human melanoma. Lymphat Res Biol. 2012;10(3):107\u201311.","journal-title":"Lymphat Res Biol"},{"key":"4171_CR108","doi-asserted-by":"crossref","unstructured":"Hollander W, Reilly P, Burrows B, et al. Lymphatic flow in human subjects as indicated by the disappearance of i$$^{131}$$-labeled albumin from the subcutaneous tissue. J Clin Investig. 1961;40(2):222\u201333.","DOI":"10.1172\/JCI104248"},{"issue":"3","key":"4171_CR109","first-page":"318","volume":"43","author":"SJ Pain","year":"2002","unstructured":"Pain SJ, Nicholas RS, Barber RW, Ballinger JR, Purushotham AD, Mortimer PS, et al. Quantification of lymphatic function for investigation of lymphedema: depot clearance and rate of appearance of soluble macromolecules in blood. J Nucl Med. 2002;43(3):318\u201324.","journal-title":"J Nucl Med"},{"issue":"2","key":"4171_CR110","doi-asserted-by":"publisher","first-page":"H391","DOI":"10.1152\/ajpheart.00842.2011","volume":"302","author":"TV Karlsen","year":"2012","unstructured":"Karlsen TV, McCormack E, Mujic M, Tenstad O, Wiig H. Minimally invasive quantification of lymph flow in mice and rats by imaging depot clearance of near-infrared albumin. Am J Physiol Heart Circul Physiol. 2012;302(2):H391\u2013401.","journal-title":"Am J Physiol Heart Circul Physiol"},{"key":"4171_CR111","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1007\/s11095-021-03032-w","volume":"38","author":"F Zheng","year":"2021","unstructured":"Zheng F, Hou P, Corpstein CD, Xing L, Li T. Multiphysics modeling and simulation of subcutaneous injection and absorption of biotherapeutics: model development. Pharm Res. 2021;38:607\u201324.","journal-title":"Pharm Res"},{"issue":"3","key":"4171_CR112","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1016\/j.xphs.2021.09.045","volume":"111","author":"D Han","year":"2022","unstructured":"Han D, Rahimi E, Aramideh S, Ardekani AM. Transport and lymphatic uptake of biotherapeutics through subcutaneous injection. J Pharm Sci. 2022;111(3):752\u201368.","journal-title":"J Pharm Sci"},{"key":"4171_CR113","doi-asserted-by":"crossref","unstructured":"Han D, Li C, Araimdeh S, Sree V, Rahimi E, Tepole AB, et al. Lymphatic uptake of biotherapeutics through a 3D hybrid discrete-continuum vessel network in the skin tissue. J Control Release. 2023;354:869\u201388.","DOI":"10.1016\/j.jconrel.2022.12.045"},{"key":"4171_CR114","doi-asserted-by":"publisher","DOI":"10.1016\/j.cma.2021.113919","volume":"384","author":"Y Leng","year":"2021","unstructured":"Leng Y, de Lucio M, Gomez H. Using poro-elasticity to model the large deformation of tissue during subcutaneous injection. Comput Methods Appl Mech Eng. 2021;384:113919.","journal-title":"Comput Methods Appl Mech Eng"},{"key":"4171_CR115","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmbbm.2022.105602","volume":"138","author":"M de Lucio","year":"2023","unstructured":"de Lucio M, Leng Y, Hans A, Bilionis I, Brindise M, Ardekani AM, et al. Modeling large-volume subcutaneous injection of monoclonal antibodies with anisotropic porohyperelastic models and data-driven tissue layer geometries. J Mech Behav Biomed Mater. 2023;138:105602.","journal-title":"J Mech Behav Biomed Mater"},{"issue":"6","key":"4171_CR116","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1007\/s10237-023-01746-x","volume":"22","author":"M de Lucio","year":"2023","unstructured":"de Lucio M, Leng Y, Wang H, Ardekani AM, Vlachos PP, Shi G, et al. Computational modeling of the effect of skin pinch and stretch on subcutaneous injection of monoclonal antibodies using autoinjector devices. Biomech Model Mechanobiol. 2023;22(6):1965\u201382.","journal-title":"Biomech Model Mechanobiol"},{"key":"4171_CR117","doi-asserted-by":"crossref","unstructured":"Leng Y, Ardekani AM, Gomez H. A poro-viscoelastic model for the subcutaneous injection of monoclonal antibodies. J Mech Phys Solids. 2021;155:104537.","DOI":"10.1016\/j.jmps.2021.104537"},{"key":"4171_CR118","doi-asserted-by":"crossref","unstructured":"Han D, Huang Z, Rahimi E, Ardekani AM. Solute transport across the lymphatic vasculature in a soft skin tissue. Biology. 2023;12(7):942.","DOI":"10.3390\/biology12070942"},{"key":"4171_CR119","doi-asserted-by":"crossref","unstructured":"Li C, Zhong X, Rahimi E, Ardekani AM. A multi-scale numerical study of monoclonal antibodies uptake by initial lymphatics after subcutaneous injection. Int J Pharm. 2024;661:124419.","DOI":"10.1016\/j.ijpharm.2024.124419"},{"key":"4171_CR120","doi-asserted-by":"crossref","unstructured":"de Lucio M, Leng Y, Wang H, Vlachos PP, Gomez H. Modeling drug transport and absorption in subcutaneous injection of monoclonal antibodies: Impact of tissue deformation, devices, and physiology. Int J Pharm. 2024;661:124446.","DOI":"10.1016\/j.ijpharm.2024.124446"}],"container-title":["Pharmaceutical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-026-04171-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11095-026-04171-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-026-04171-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T17:02:24Z","timestamp":1790010144000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11095-026-04171-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":120,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["4171"],"URL":"https:\/\/doi.org\/10.1007\/s11095-026-04171-8","relation":{},"ISSN":["0724-8741","1573-904X"],"issn-type":[{"value":"0724-8741","type":"print"},{"value":"1573-904X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"17 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors have no conflicts of interest to declare that are relevant to the content of this article.","order":1,"name":"Ethics","label":"Conflict of interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}